(TPE) PVA TePla - Overview
Stock: Crystal Growing, Plasma Cleaning, Metrology, Surface Treatment, Heat Treatment
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 78.8% |
| Relative Tail Risk | -12.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.02 |
| Alpha | 52.29 |
| Character TTM | |
|---|---|
| Beta | 0.569 |
| Beta Downside | 0.937 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.68% |
| CAGR/Max DD | -0.07 |
Description: TPE PVA TePla December 28, 2025
PVA TePla AG (XETRA:TPE) supplies specialized production equipment for energy-storage components, photovoltaic modules and wind-turbine parts, operating through two divisions: Semiconductor Systems (crystal-growth, metrology and plasma cleaning tools) and Industrial Systems (material-processing, surface-treatment and process-monitoring solutions for sectors such as medical, automotive and aerospace). The firm’s global footprint spans Germany, France, Italy, Switzerland, the United States, China, Taiwan, Korea and Singapore, and it also offers ancillary services like soldering, welding and heat-treatment.
Key metrics (FY 2023) show €450 million in revenue with a 7 % YoY growth rate, driven largely by a 12 % increase in orders from the renewable-energy and semiconductor equipment segments. The company’s order backlog sits at roughly €250 million, indicating a multi-quarter pipeline that is sensitive to semiconductor capex cycles and the accelerating global push for renewable-energy capacity (IEA forecasts ~30 % annual growth in solar-module installations through 2027). Currency exposure is mitigated by a balanced cost base across Europe and Asia, but earnings remain vulnerable to supply-chain disruptions in high-purity silicon and specialty gases.
If you want a data-rich, quantitative deep-dive on TPE’s valuation and risk profile, a quick look at ValueRay’s analytics may help you spot any hidden upside or downside.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 15.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -3.60 > 1.0 |
| NWC/Revenue: 29.90% < 20% (prev 34.28%; Δ -4.37% < -1%) |
| CFO/TA 0.11 > 3% & CFO 31.0m > Net Income 15.5m |
| Net Debt (32.8m) to EBITDA (35.0m): 0.94 < 3 |
| Current Ratio: 1.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (20.4m) vs 12m ago -4.93% < -2% |
| Gross Margin: 33.38% > 18% (prev 0.31%; Δ 3307 % > 0.5%) |
| Asset Turnover: 81.98% > 50% (prev 86.98%; Δ -5.00% > 0%) |
| Interest Coverage Ratio: 10.84 > 6 (EBITDA TTM 35.0m / Interest Expense TTM 2.33m) |
Altman Z'' 5.82
| A: 0.25 (Total Current Assets 183.3m - Total Current Liabilities 109.4m) / Total Assets 292.1m |
| B: 0.47 (Retained Earnings 137.7m / Total Assets 292.1m) |
| C: 0.08 (EBIT TTM 25.2m / Avg Total Assets 301.6m) |
| D: 1.96 (Book Value of Equity 297.1m / Total Liabilities 151.6m) |
| Altman-Z'' Score: 5.82 = AAA |
Beneish M -3.19
| DSRI: 1.04 (Receivables 91.4m/95.8m, Revenue 247.2m/270.6m) |
| GMI: 0.93 (GM 33.38% / 30.95%) |
| AQI: 0.98 (AQ_t 0.13 / AQ_t-1 0.13) |
| SGI: 0.91 (Revenue 247.2m / 270.6m) |
| TATA: -0.05 (NI 15.5m - CFO 31.0m) / TA 292.1m) |
| Beneish M-Score: -3.19 (Cap -4..+1) = AA |
What is the price of TPE shares?
Over the past week, the price has changed by -20.82%, over one month by -15.75%, over three months by -12.03% and over the past year by +55.74%.
Is TPE a buy, sell or hold?
What are the forecasts/targets for the TPE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30.3 | 46.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 22.5 | 8.6% |
TPE Fundamental Data Overview February 09, 2026
P/E Trailing = 28.4384
P/E Forward = 17.6056
P/S = 1.7148
P/B = 3.0178
Revenue TTM = 247.2m EUR
EBIT TTM = 25.2m EUR
EBITDA TTM = 35.0m EUR
Long Term Debt = 20.6m EUR (from longTermDebt, last quarter)
Short Term Debt = 24.7m EUR (from shortTermDebt, last quarter)
Debt = 45.3m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 32.8m EUR (from netDebt column, last quarter)
Enterprise Value = 456.7m EUR (424.0m + Debt 45.3m - CCE 12.6m)
Interest Coverage Ratio = 10.84 (Ebit TTM 25.2m / Interest Expense TTM 2.33m)
EV/FCF = 419.0x (Enterprise Value 456.7m / FCF TTM 1.09m)
FCF Yield = 0.24% (FCF TTM 1.09m / Enterprise Value 456.7m)
FCF Margin = 0.44% (FCF TTM 1.09m / Revenue TTM 247.2m)
Net Margin = 6.26% (Net Income TTM 15.5m / Revenue TTM 247.2m)
Gross Margin = 33.38% ((Revenue TTM 247.2m - Cost of Revenue TTM 164.7m) / Revenue TTM)
Gross Margin QoQ = 29.43% (prev 33.53%)
Tobins Q-Ratio = 1.56 (Enterprise Value 456.7m / Total Assets 292.1m)
Interest Expense / Debt = 1.64% (Interest Expense 745.0k / Debt 45.3m)
Taxrate = 30.50% (11.9m / 39.0m)
NOPAT = 17.5m (EBIT 25.2m * (1 - 30.50%))
Current Ratio = 1.68 (Total Current Assets 183.3m / Total Current Liabilities 109.4m)
Debt / Equity = 0.32 (Debt 45.3m / totalStockholderEquity, last quarter 140.5m)
Debt / EBITDA = 0.94 (Net Debt 32.8m / EBITDA 35.0m)
Debt / FCF = 30.05 (Net Debt 32.8m / FCF TTM 1.09m)
Total Stockholder Equity = 144.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.13% (Net Income 15.5m / Total Assets 292.1m)
RoE = 10.73% (Net Income TTM 15.5m / Total Stockholder Equity 144.2m)
RoCE = 15.29% (EBIT 25.2m / Capital Employed (Equity 144.2m + L.T.Debt 20.6m))
RoIC = 11.78% (NOPAT 17.5m / Invested Capital 148.7m)
WACC = 7.35% (E(424.0m)/V(469.3m) * Re(8.01%) + D(45.3m)/V(469.3m) * Rd(1.64%) * (1-Tc(0.31)))
Discount Rate = 8.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.10%
[DCF Debug] Terminal Value 73.31% ; FCFF base≈5.60m ; Y1≈3.68m ; Y5≈1.68m
Fair Price DCF = 0.22 (EV 37.2m - Net Debt 32.8m = Equity 4.40m / Shares 20.4m; r=7.35% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 3.17 | EPS CAGR: -44.45% | SUE: -0.54 | # QB: 0
Revenue Correlation: 56.75 | Revenue CAGR: 8.95% | SUE: -0.40 | # QB: 0
EPS next Year (2026-12-31): EPS=0.88 | Chg30d=-0.166 | Revisions Net=-2 | Growth EPS=+72.4% | Growth Revenue=+13.9%